Company Filing History:
Years Active: 2008
Title: The Innovative Contributions of Ivy Jiang
Introduction
Ivy Jiang is a prominent inventor based in San Diego, CA, known for her significant contributions to the field of immunology. With a focus on developing therapeutic solutions for anthrax, she has made strides in generating human antibodies that can be used for both treatment and prevention.
Latest Patents
Ivy Jiang holds 2 patents related to her groundbreaking work on antibodies against protective antigens. Her latest patents include methods for generating human antibodies using recall technology, specifically targeting the anthrax toxin. This innovative approach utilizes human peripheral blood cells that have been pre-exposed to anthrax toxin in a SCID mouse model. The result is a high yield of human antibody titers, primarily of the IgG isotype, which exhibit high specificity and affinity for the desired antigens. These antibodies have the potential to be used therapeutically and prophylactically to prevent or treat anthrax exposure, particularly in scenarios involving bioterrorism. Additionally, her patents describe formulations and methods for diagnosing anthrax contamination.
Career Highlights
Ivy Jiang is currently employed at Emergent Product Development Gaithersburg Inc., where she continues to advance her research in immunology. Her work is pivotal in developing effective treatments for anthrax, showcasing her dedication to public health and safety.
Collaborations
Ivy collaborates with several professionals in her field, including Jeanne Morrow, a legal representative, and Angray Singh Kang. These collaborations enhance her research efforts and contribute to the successful development of her innovative solutions.
Conclusion
Ivy Jiang's contributions to the field of immunology, particularly in the development of antibodies against anthrax, highlight her role as a leading inventor. Her innovative methods and dedication to public health continue to make a significant impact in the fight against bioterrorism and infectious diseases.